iBio (IBIO) Non-Current Assets (2011 - 2026)
iBio's (IBIO) quarterly Non-Current Assets came in at $8.6 million in Q1 2026, down 34.19% year-on-year from $13.0 million in Q1 2025, and down 21.92% on a QoQ basis from $11.0 million in Q4 2025.
iBio (IBIO) Non-Current Assets (2011 - 2026) Analysis & Trends
iBio (IBIO) has 16 years of Non-Current Assets data on file, last reported at $8.6 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 34.19% year-over-year to $8.6 million in Q1 2026; TTM through Mar 2026 was $46.4 million, a 11.35% decrease from a year earlier, with the FY2025 full-year figure at $13.5 million, up 3.08% from the prior year.
- Non-Current Assets for Q1 2026 stood at $8.6 million, down from $11.0 million in the prior quarter.
- Over the last five years, Non-Current Assets for IBIO reached as high as $55.1 million in Q1 2022 and fell as low as $8.6 million in Q1 2026.
- Historically, Non-Current Assets has averaged $18.7 million across 5 years, with a median of $13.6 million in 2022.
- On a YoY basis, Non-Current Assets climbed as much as 55.11% in 2022 and fell as far as 76.99% in 2022.
- Year by year, Non-Current Assets stood at $13.6 million in 2022, then rose by 5.59% to $14.3 million in 2023, then decreased by 6.36% to $13.4 million in 2024, then dropped by 18.04% to $11.0 million in 2025, then declined by 21.92% to $8.6 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $8.6 million in Q1 2026, $11.0 million in Q4 2025, and $13.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 472.06 Bn | 467.27 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 122.10 Bn | 114.85 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.25 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.50 Bn | 959.66 Mn | 910.24 Mn |
| 10 | iBio | 166.24 Mn | 166.24 Mn | - | 8.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.58 Mn |
| Dec 31, 2025 | 10.99 Mn |
| Sep 30, 2025 | 13.36 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Mar 31, 2025 | 13.04 Mn |
| Dec 31, 2024 | 13.41 Mn |
| Sep 30, 2024 | 12.82 Mn |
| Jun 30, 2024 | 13.06 Mn |
| Mar 31, 2024 | 14.02 Mn |
| Dec 31, 2023 | 14.32 Mn |
| Sep 30, 2023 | 14.66 Mn |
| Jun 30, 2023 | 14.95 Mn |
| Mar 31, 2023 | 17.29 Mn |
| Dec 31, 2022 | 13.57 Mn |
| Sep 30, 2022 | 21.00 Mn |
| Jun 30, 2022 | 54.34 Mn |
| Mar 31, 2022 | 55.05 Mn |
| Dec 31, 2021 | 58.95 Mn |
| Sep 30, 2021 | 53.92 Mn |
| Jun 30, 2021 | 42.37 Mn |